Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/511

Authors: KRIS MG
Citation: Mg. Kris, LUNG-CANCER CURE, CARE, AND COST - LET THE DATA BE YOUR GUIDE, Journal of clinical oncology, 15(9), 1997, pp. 3027-3029

Authors: WORK E NIELSEN OS BENTZEN SM FODE K PALSHOF T
Citation: E. Work et al., RANDOMIZED STUDY OF INITIAL VERSUS LATE CHEST IRRADIATION COMBINED WITH CHEMOTHERAPY IN LIMITED-STAGE SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3030-3037

Authors: EVANS WK WILL P BERTHELOT JM EARLE CC
Citation: Wk. Evans et al., COST OF COMBINED-MODALITY INTERVENTIONS FOR STAGE-III NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3038-3048

Authors: EVANS WK NEWMAN T GRAHAM I RUSTHOVEN JJ LOGAN D SHEPHERD FA CHAMBERLAIN D
Citation: Wk. Evans et al., LUNG-CANCER PRACTICE GUIDELINES - LESSONS LEARNED AND ISSUES ADDRESSED BY THE ONTARIO-LUNG-CANCER-DISEASE-SITE-GROUP, Journal of clinical oncology, 15(9), 1997, pp. 3049-3059

Authors: BODIS S KRAUS MD PINKUS G SILVER B KADIN ME CANELLOS GP SHULMAN LN TARBELL NJ MAUCH PM
Citation: S. Bodis et al., CLINICAL PRESENTATION AND OUTCOME IN LYMPHOCYTE-PREDOMINANT HODGKINS-DISEASE, Journal of clinical oncology, 15(9), 1997, pp. 3060-3066

Authors: BROWN RA ADKINS D GOODNOUGH LT HAUG JS TODD G WEHDE M HENDRICKS D EHLENBECK C LAUB L DIPERSIO J
Citation: Ra. Brown et al., FACTORS THAT INFLUENCE THE COLLECTION AND ENGRAFTMENT OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 15(9), 1997, pp. 3067-3074

Authors: NAG S MARTINEZMONGE R RUYMANN F JAMIL A BAUER C
Citation: S. Nag et al., INNOVATION IN THE MANAGEMENT OF SOFT-TISSUE SARCOMAS IN INFANTS AND YOUNG-CHILDREN - HIGH-DOSE-RATE BRACHYTHERAPY, Journal of clinical oncology, 15(9), 1997, pp. 3075-3084

Authors: KROWN SE TESTA MA HUANG J
Citation: Se. Krown et al., AIDS-RELATED KAPOSIS-SARCOMA - PROSPECTIVE VALIDATION OF THE AIDS CLINICAL-TRIALS GROUP STAGING CLASSIFICATION, Journal of clinical oncology, 15(9), 1997, pp. 3085-3092

Authors: LOEHRER PJ CHEN M KIM KM AISNER SC EINHORN LH LIVINGSTON R JOHNSON D
Citation: Pj. Loehrer et al., CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE PLUS THORACIC RADIATION-THERAPY FOR LIMITED-STAGE UNRESECTABLE THYMOMA - AN INTERGROUP TRIAL, Journal of clinical oncology, 15(9), 1997, pp. 3093-3099

Authors: CLARK JR BUSSE PM NORRIS CM ANDERSEN JW DREYFUSS AI ROSSI RM POULIN MD COLEVAS AD TISHLER RB COSTELLO R LUCARINI JW LUCARINI D THORNHILL L LACKEY M PETERS E POSNER MR
Citation: Jr. Clark et al., INDUCTION CHEMOTHERAPY WITH CISPLATIN, FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - LONG-TERM RESULTS, Journal of clinical oncology, 15(9), 1997, pp. 3100-3110

Authors: HIRVIKOSKI P KUMPULAINEN E VIRTANIEMI J JOHANSSON R HAAPASALO H MARIN S HALONEN P HELIN H RAITIOLA H PUKANDER J KELLOKUMPULEHTINEN P KOSMA VM
Citation: P. Hirvikoski et al., P53 EXPRESSION AND CELL-PROLIFERATION AS PROGNOSTIC FACTORS IN LARYNGEAL SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 15(9), 1997, pp. 3111-3120

Authors: FETELL MR GROSSMAN SA FISHER JD ERLANGER B ROWINSKY E STOCKEL J PIANTADOSI S
Citation: Mr. Fetell et al., PREIRRADIATION PACLITAXEL IN GLIOBLASTOMA-MULTIFORME - EFFICACY, PHARMACOLOGY, AND DRUG-INTERACTIONS, Journal of clinical oncology, 15(9), 1997, pp. 3121-3128

Authors: LOTE K EGELAND T HAGER B STENWIG B SKULLERUD K BERGJOHNSEN J STORMMATHISEN I HIRSCHBERG H
Citation: K. Lote et al., SURVIVAL, PROGNOSTIC FACTORS, AND THERAPEUTIC EFFICACY IN LOW-GRADE GLIOMA - A RETROSPECTIVE STUDY IN 379 PATIENTS, Journal of clinical oncology, 15(9), 1997, pp. 3129-3140

Authors: BYRNE MJ GEBSKI V FORBES J TATTERSALL MHN SIMES RJ COATES AS DEWAR J LUNN M FLOWER C GILL PG STEWART J
Citation: Mj. Byrne et al., MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL, Journal of clinical oncology, 15(9), 1997, pp. 3141-3148

Authors: PICCART MJ KLIJN J PARIDAENS R NOOIJ M MAURIAC L COLEMAN R BONTENBAL M AWADA A SELLESLAGS J VANVRECKEM A VANGLABBEKE M
Citation: Mj. Piccart et al., CORTICOSTEROIDS SIGNIFICANTLY DELAY THE ONSET OF DOCETAXEL-INDUCED FLUID RETENTION - FINAL RESULTS OF A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3149-3155

Authors: HUDES GR NATHAN F KHATER C HAAS N CORNFIELD M GIANTONIO B GREENBERG R GOMELLA L LITWIN S ROSS E ROETHKE S MCALEER C
Citation: Gr. Hudes et al., PHASE-II TRIAL OF 96-HOUR PACLITAXEL PLUS ORAL ESTRAMUSTINE PHOSPHATEIN METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3156-3163

Authors: JUCGLA A SAIS G
Citation: A. Jucgla et G. Sais, HAND-FOOT SYNDROME, Journal of clinical oncology, 15(9), 1997, pp. 3164-3164

Authors: STEYERBERG EW KEIZER HJ SLEIJFER DT
Citation: Ew. Steyerberg et al., POSTCHEMOTHERAPY SURGERY IN NONSEMINOMA, Journal of clinical oncology, 15(9), 1997, pp. 3165-3166

Authors: EINHORN LH
Citation: Lh. Einhorn, POSTCHEMOTHERAPY SURGERY IN NONSEMINOMA - REPLY, Journal of clinical oncology, 15(9), 1997, pp. 3166-3166

Authors: BESA EC
Citation: Ec. Besa, IS MINIMAL RESIDUAL DISEASE IN THE PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION OF CHRONIC MYELOGENOUS LEUKEMIA IMPORTANT, Journal of clinical oncology, 15(9), 1997, pp. 3166-3166

Authors: CARELLA AM CORSETTI MT FRASSONI F
Citation: Am. Carella et al., IS MINIMAL RESIDUAL DISEASE IN THE PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION OF CHRONIC MYELOGENOUS LEUKEMIA IMPORTANT - REPLY, Journal of clinical oncology, 15(9), 1997, pp. 3167-3167

Authors: LOPRINZI CL SLOAN J KUGLER J
Citation: Cl. Loprinzi et al., COUMARIN-INDUCED HEPATOTOXICITY, Journal of clinical oncology, 15(9), 1997, pp. 3167-3168

Authors: BOWER
Citation: Bower, EMA CO FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS - RESULTS FROM A COHORT OF 272 PATIENTS (VOL 15, PG 2636, 1997)/, Journal of clinical oncology, 15(9), 1997, pp. 3168-3168

Authors: SIU LL TANNOCK IF
Citation: Ll. Siu et If. Tannock, CHEMOTHERAPY DOSE-ESCALATION - CASE UNPROVED, Journal of clinical oncology, 15(8), 1997, pp. 2765-2768

Authors: WEINER MA LEVENTHAL B BRECHER ML MARCUS RB CANTER A GIESER PW TERNBERG JL BEHM FG WHARAM MD CHAUVENET AR
Citation: Ma. Weiner et al., RANDOMIZED STUDY OF INTENSIVE MOPP-ABVD WITH OR WITHOUT LOW-DOSE TOTAL-NODAL RADIATION-THERAPY IN THE TREATMENT OF STAGE-IIB, STAGE-IIIA2, STAGE-IIIB, AND STAGE-IV HODGKINS-DISEASE IN PEDIATRIC-PATIENTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(8), 1997, pp. 2769-2779
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>